Parexel International Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- GDPH63385D
- Pages: 53
- November 2018
- Total Views:1144
- Region : North America
- GlobalData
- Equity Research Report
Details
Summary
Parexel International Corp (Parexel) is a biopharmaceutical outsourcing service company which focuses on providing various services for managing the biopharmaceutical product lifecycle and for the development and commercialization of new medical therapies. It offers a comprehensive range of services including clinical trials management, observational studies and patient/disease registries, data management, biostatistical analysis, epidemiology, health economics/outcomes research, pharmacovigilance, medical communications, clinical pharmacology, patient recruitment, clinical supply and drug logistics, post-marketing surveillance, regulatory and product development and commercialization consulting among several others. Parexel caters its products and services to pharmaceutical, biotechnology and medical device industries worldwide. The company offers its services through a network of offices in various countries across the world. Parexel is headquartered in Waltham, Massachusetts, the US.
Parexel International Corp-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table Of Content
Scope
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Parexel International Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Parexel International Corp, Medical Devices Deals, 2012 to YTD 2018 10
Parexel International Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Parexel International Corp, Pharmaceuticals & Healthcare, Deal Details 12
Private Equity 12
Pamplona Capital Management Acquires Parexel International for USD5 Billion 12
Partnerships 14
Parexel Enters into Agreement with Microsoft 14
Parexel Enters into Agreement with Osaka International Cancer 15
InDex Pharma Enters into Agreement with Parexel 16
Polus Enters into Agreement with Parexel 17
Parexel International Enters Into Agreement With National Taiwan University Hospital 18
Debt Offering 19
Parexel International Completes Private Placement Of Notes Due 2020 For USD 100 Million 19
Acquisition 20
Parexel International Acquires Medical Affairs Company 20
Parexel International Acquires Quantum Solutions, Contract Research Organization 21
Parexel Acquires ClinIntel 22
Parexel International Acquires Atlas Medical 23
Parexel Acquires Heron Group For USD37 Million 24
Parexel International Acquires Liquent For USD74.3 Million 25
Parexel International Corp-Key Competitors 26
Parexel International Corp-Key Employees 27
Parexel International Corp-Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 33
Financial Announcements 33
Aug 28, 2017: PAREXEL International Reports Fourth Quarter and Fiscal Year 2017 Results 33
May 03, 2017: PAREXEL International Reports Third Quarter Fiscal Year 2017 Results 34
Feb 01, 2017: PAREXEL International Reports Second Quarter Fiscal Year 2017 Results 36
Corporate Communications 38
Nov 12, 2018: Parexel announces appointment of new members to its Board of Directors 38
Aug 16, 2018: PAREXEL announces appointment of two key executives 40
Apr 25, 2018: PAREXEL Names Peyton Howell as Chief Commercial and Strategy Officer 41
Mar 05, 2018: PAREXEL Names Jamie Macdonald As Chief Executive Officer 42
Feb 28, 2017: PAREXEL International Appoints Simon Harford as Senior Vice President and Chief Financial Officer 43
Government and Public Interest 44
May 15, 2018: CRO Industry Update: Big Data Drives Drug Development Efforts 44
Other Significant Developments 47
Oct 31, 2018: PAREXEL navigates China's complex drug development and market landscape for global biopharmaceutical companies with new China Advisory Service 47
Sep 11, 2018: PAREXEL advances patient-centric drug development with introduction of its patient innovation center 48
Mar 21, 2018: PAREXEL Introduces Integrated Medical Writing Solutions Service Offering 49
Feb 12, 2018: PAREXEL Introduces Biological Sample Lifecycle Management Service to Address Growing Demand Across Drug Development 50
Sep 06, 2017: PAREXEL Launches Real-World Data Service Offering to Drive Value Demonstration of New Treatments 51
Jun 19, 2017: PAREXEL Introduces Its Connected Journey of Newly Integrated Data-Driven Services to Simplify Drug Development and Commercialization 52
Appendix 53
Methodology 53
About GlobalData 53
Contact Us 53
Disclaimer 53
List Of Figure
List of Figures
Parexel International Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Parexel International Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Parexel International Corp, Medical Devices Deals, 2012 to YTD 2018 10
List Of Table
List of Tables
Parexel International Corp, Pharmaceuticals & Healthcare, Key Facts 2
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Parexel International Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Parexel International Corp, Deals By Therapy Area, 2012 to YTD 2018 9
Parexel International Corp, Medical Devices Deals, 2012 to YTD 2018 10
Parexel International Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Pamplona Capital Management Acquires Parexel International for USD5 Billion 12
Parexel Enters into Agreement with Microsoft 14
Parexel Enters into Agreement with Osaka International Cancer 15
InDex Pharma Enters into Agreement with Parexel 16
Polus Enters into Agreement with Parexel 17
Parexel International Enters Into Agreement With National Taiwan University Hospital 18
Parexel International Completes Private Placement Of Notes Due 2020 For USD 100 Million 19
Parexel International Acquires Medical Affairs Company 20
Parexel International Acquires Quantum Solutions, Contract Research Organization 21
Parexel Acquires ClinIntel 22
Parexel International Acquires Atlas Medical 23
Parexel Acquires Heron Group For USD37 Million 24
Parexel International Acquires Liquent For USD74.3 Million 25
Parexel International Corp, Key Competitors 26
Parexel International Corp, Key Employees 27
Parexel International Corp, Other Locations 28
Parexel International Corp, Subsidiaries 29
Licence Rights
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Section Purchase
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products and Companies
Products
Parexel International Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Company Profile
Company Profile Title
Summary
Parexel International Corp (Parexel) is a biopharmaceutical outsourcing service company which focuses on providing various services for managing the biopharmaceutical product lifecycle and for the development and commercialization of new medical therapies. It offers a comprehensive range of services including clinical trials management, observational studies and patient/disease registries, data management, biostatistical analysis, epidemiology, health economics/outcomes research, pharmacovigilance, medical communications, clinical pharmacology, patient recruitment, clinical supply and drug logistics, post-marketing surveillance, regulatory and product development and commercialization consulting among several others. Parexel caters its products and services to pharmaceutical, biotechnology and medical device industries worldwide. The company offers its services through a network of offices in various countries across the world. Parexel is headquartered in Waltham, Massachusetts, the US.
Parexel International Corp-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Scope
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Parexel International Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Parexel International Corp, Medical Devices Deals, 2012 to YTD 2018 10
Parexel International Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Parexel International Corp, Pharmaceuticals & Healthcare, Deal Details 12
Private Equity 12
Pamplona Capital Management Acquires Parexel International for USD5 Billion 12
Partnerships 14
Parexel Enters into Agreement with Microsoft 14
Parexel Enters into Agreement with Osaka International Cancer 15
InDex Pharma Enters into Agreement with Parexel 16
Polus Enters into Agreement with Parexel 17
Parexel International Enters Into Agreement With National Taiwan University Hospital 18
Debt Offering 19
Parexel International Completes Private Placement Of Notes Due 2020 For USD 100 Million 19
Acquisition 20
Parexel International Acquires Medical Affairs Company 20
Parexel International Acquires Quantum Solutions, Contract Research Organization 21
Parexel Acquires ClinIntel 22
Parexel International Acquires Atlas Medical 23
Parexel Acquires Heron Group For USD37 Million 24
Parexel International Acquires Liquent For USD74.3 Million 25
Parexel International Corp-Key Competitors 26
Parexel International Corp-Key Employees 27
Parexel International Corp-Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 33
Financial Announcements 33
Aug 28, 2017: PAREXEL International Reports Fourth Quarter and Fiscal Year 2017 Results 33
May 03, 2017: PAREXEL International Reports Third Quarter Fiscal Year 2017 Results 34
Feb 01, 2017: PAREXEL International Reports Second Quarter Fiscal Year 2017 Results 36
Corporate Communications 38
Nov 12, 2018: Parexel announces appointment of new members to its Board of Directors 38
Aug 16, 2018: PAREXEL announces appointment of two key executives 40
Apr 25, 2018: PAREXEL Names Peyton Howell as Chief Commercial and Strategy Officer 41
Mar 05, 2018: PAREXEL Names Jamie Macdonald As Chief Executive Officer 42
Feb 28, 2017: PAREXEL International Appoints Simon Harford as Senior Vice President and Chief Financial Officer 43
Government and Public Interest 44
May 15, 2018: CRO Industry Update: Big Data Drives Drug Development Efforts 44
Other Significant Developments 47
Oct 31, 2018: PAREXEL navigates China's complex drug development and market landscape for global biopharmaceutical companies with new China Advisory Service 47
Sep 11, 2018: PAREXEL advances patient-centric drug development with introduction of its patient innovation center 48
Mar 21, 2018: PAREXEL Introduces Integrated Medical Writing Solutions Service Offering 49
Feb 12, 2018: PAREXEL Introduces Biological Sample Lifecycle Management Service to Address Growing Demand Across Drug Development 50
Sep 06, 2017: PAREXEL Launches Real-World Data Service Offering to Drive Value Demonstration of New Treatments 51
Jun 19, 2017: PAREXEL Introduces Its Connected Journey of Newly Integrated Data-Driven Services to Simplify Drug Development and Commercialization 52
Appendix 53
Methodology 53
About GlobalData 53
Contact Us 53
Disclaimer 53
List Of Figure
List of Figures
Parexel International Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Parexel International Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Parexel International Corp, Medical Devices Deals, 2012 to YTD 2018 10
List Of Table
List of Tables
Parexel International Corp, Pharmaceuticals & Healthcare, Key Facts 2
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Parexel International Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Parexel International Corp, Deals By Therapy Area, 2012 to YTD 2018 9
Parexel International Corp, Medical Devices Deals, 2012 to YTD 2018 10
Parexel International Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Pamplona Capital Management Acquires Parexel International for USD5 Billion 12
Parexel Enters into Agreement with Microsoft 14
Parexel Enters into Agreement with Osaka International Cancer 15
InDex Pharma Enters into Agreement with Parexel 16
Polus Enters into Agreement with Parexel 17
Parexel International Enters Into Agreement With National Taiwan University Hospital 18
Parexel International Completes Private Placement Of Notes Due 2020 For USD 100 Million 19
Parexel International Acquires Medical Affairs Company 20
Parexel International Acquires Quantum Solutions, Contract Research Organization 21
Parexel Acquires ClinIntel 22
Parexel International Acquires Atlas Medical 23
Parexel Acquires Heron Group For USD37 Million 24
Parexel International Acquires Liquent For USD74.3 Million 25
Parexel International Corp, Key Competitors 26
Parexel International Corp, Key Employees 27
Parexel International Corp, Other Locations 28
Parexel International Corp, Subsidiaries 29
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products
Parexel International Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Ask A Question
Our Team Will Assist You in What You Are Looking For
or 
: +91 98100 26150
: ankurgupta1984
Related Reports
Page 130 | 
December 2020
Page 130 | December 2020
Page 131 | November 2020
Page 95 | November 2020
Page 96 | August 2020